JDD Corner

JDD December 2023 Issue Highlights
by NEXT STEPS IN DERM TEAM on
Welcome to the December 2023 issue of the Journal of Drugs in Dermatology (JDD), where cutting-edge research and advancements in the field of dermatology take center stage. This issue brings together a diverse array of original articles, case reports, brief communications, and letters to the editor and delves into the latest developments, therapeutic breakthroughs, and cl …

Continue reading "JDD December 2023 Issue Highlights"

Eruptive Squamous Cell Carcinomas Following Treatment With Fludarabine
Eruptive squamous cell carcinoma
by NEXT STEPS IN DERM TEAM on
JDD authors Mihir Shah MD, Jenna Wald MD, and C. William Hanke MD MPH present a case of a patient with eruptive squamous cell carcinomas following treatment with Fludarabine to highlight not only the risk of cSCC in CLL patients and the increased risk for atypical cutaneous malignancies after treatment with systemic therapies such as fludarabine, but also to discuss treatment options for this …

Continue reading "Eruptive Squamous Cell Carcinomas Following Treatment With Fludarabine"

JDD November 2023 Issue Highlights | Special Topic: Lasers, Light Sources, and Devices
laser treatment
by NEXT STEPS IN DERM TEAM on
The November 2023 issue of the Journal of Drugs in Dermatology (JDD) focuses on lasers, light sources, and devices featuring the perfect mix original articles, case reports, letters to the editor, and brief communications. Straight from the Editor’s desk, check out this month’s issue highlights. ORIGINAL ARTICLES Interventions to Minimize Pain During Photodynamic Therapy With 5-Aminolevulini …

Continue reading "JDD November 2023 Issue Highlights | Special Topic: Lasers, Light Sources, and Devices"

Refractory Dissecting Cellulitis of the Scalp Treated With Risankizumab
Dissecting Cellulitis
by NEXT STEPS IN DERM TEAM on
Perifolliculitis capitis abscedens et suffodiens or dissecting cellulitis (DC) is a rare and chronic disease with a predilection for the occipital, vertex, and parietal scalp. DC is characterized by multinodular lesions with purulent drainage and sinus tract formation. It is classically seen in middle-aged males of African descent. The etiology of the disease is unknown; however, leading theories …

Continue reading "Refractory Dissecting Cellulitis of the Scalp Treated With Risankizumab"

JDD October 2023 Issue Highlights | Special Topic: Atopic Dermatitis
atopic dermatitis
by NEXT STEPS IN DERM TEAM on
The October 2023 issue of the Journal of Drugs in Dermatology (JDD) focuses on atopic dermatitis and features mix of original articles, letters to the editor, and case reports. Among many of the topics explored in this issue are statins for treating actinic porokeratosis, ant venom-based ceramide therapy, the psychosocial burden of skin disease among skin of color consumers, treatment of lichen pl …

Continue reading "JDD October 2023 Issue Highlights | Special Topic: Atopic Dermatitis"